Active Ingredient History

NOW
  • Now
Fosaprepitant is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: Yes

Drug Pricing (per unit)

United States

$0.2837 - $322.9300

Australia

$51.9296 - $80.9956
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine | ((2r)-(1r)-3,5-bis(trifluoromethyl)phenylethoxy)-3-(s)-(4-fluoro)phenyl-4-(3-(1-phosphoryl-5-oxo-4h-1,2,4-triazolo))methylmorpholine | (2r)-(1r)-3,5-bis(trifluoromethylphenyl)ethoxy)-(3s)-(4-fluoro)phenyl-4-(3-(5-oxo-1h,4h-1,2,4-triazole)methyl-morpholine | 3-(((2r,3s)-3-(p-fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one | aprepitant | aprépitant | aprepitantum | apretpitant | emend | emend for injection | fosaprepitant | fosaprepitant dimeglumine | fosaprepitant meglumine | fosaprepitantum | ivemend | l 754030 | l 754,030 | l-754030 | l-754,030 | l758298 | l 758298 | l-758,298 | l 785,298 | l-785,298 | l785,298 | mk0517 | mk 0517 | mk-0517 | mk0869 | mk 0869 | mk-0869 | mk 869 | mk-869

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue